Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 43 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usualMcGregor, C.; Srisurapanont, M.; Mitchell, A.; Wickes, W.; White, J.
2003Low detection rate of antibodies to non-functional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assayLing, M.; Duncan, E.; Rodgers, S.; Street, A.; Lloyd, J.
2000Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; Dyer, K.; White, J.; Bochner, F.
2004A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryzaLatte, G.; Taverner, D.; Slobodian, P.; Shakib, S.
2004Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposureMitchell, T.; Dyer, K.; Newcombe, D.; Salter, A.; Somogyi, A.; Bochner, F.; White, J.
2007Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypesSchroth, W.; Antoniadou, L.; Fritz, P.; Schwab, M.; Muerdter, T.; Zanger, U.; Simon, W.; Eichelbaum, M.; Brauch, H.
2004Orbital myositis in Churg-Strauss syndromeBilling, K.; Malhotra, R.; Selva-Nayagam, D.; Dodd, T.
2006The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivoKirsch-Volders, M.; Mateuca, R.; Roelants, M.; Tremp, A.; Zeiger, E.; Bonassi, S.; Holland, N.; Chang, W.; Aka, P.; DeBoeck, M.; Godderis, L.; Haufroid, V.; Ishikawa, H.; Laffon, B.; Marcos, R.; Migliore, L.; Norppa, H.; Teixeira, J.; Zijno, A.; Fenech, M.
2005Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal diseaseReuter, S.; Evans, A.; Faull, R.; Chace, D.; Fornasini, G.
2002Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjectsElbrond, B.; Jakobsen, G.; Larsen, S.; Agerso, H.; Jensen, L.; Rolan, P.; Sturis, J.; Hatorp, V.; Zdravkovic, M.